Professionals and executives from the biopharma, health organizations, CROs, Digital Solutions, Policy Developers, and Medical Device Companies, are invited to attend the Health Equity In Clinical Trials Congress being held in Boston, February 22-23, 2023. Participants will get access to a wide spectrum of healthcare opportunities and the chance to meet and connect with veterans of the industry.
In the two main event days, 25+ leading industry speakers will gather on this forum to share their valuable insights in 5 keynote sessions, and will discuss tactful approaches to drive meaningful change for underrepresented communities through meaningful cross-industry networks and scaling equity initiatives. Attendees will get deeper insights from these equity change-makers to more fully understand strategies for expanding diversity, equity and inclusion programs, through industry action and technology.
The opening panel discussion topic will be on biopharma advancements for inclusive investigations and health equity programs, conducted by leading clinical trial experts in the industry.
Why attend the Clinical Trials Congress?
- Meet peers, advocates and industry experts and grow your business network
- Learn and understand from case studies, success stories, and experiences shared by your peers and leaders
- Make a list of all pointers that form a foundation for your business; strategies, roadmaps, and other insights offered by the stalwarts at the congress
- Attending the congress is a business investment that will also contribute to the personal growth of professionals and executives by increasing their knowledge base
Those interested in pitching their business or services at the conference can get curated packages that range from presenting their expertise on the main stage to hosting a private dinner. Interested candidates can partner with the event organizers at Kisaco Research to showcase their brand and make valuable new connections. There are 3 main categories: Thought Leadership, Branding & Networking.
If you would like to register a team of 3 or more, please email [email protected] for a discount coupon code before registering.
To learn more, please visit https://ibn.fm/8tTzM
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.